LONDON, May 3 /PRNewswire-FirstCall/ -- Medicsight, Inc. , a leading developer of computer-aided detection (CAD) technologies and software, and operator of Medicexchange.com, an online multi-vendor sales channel for diagnostic, treatment and surgery planning solutions, announced today that the Company has retained William Blair & Company, a Chicago-based investment firm with specialized experience in the healthcare IT sector. Medicsight has engaged the firm to assist in its strategy for commercializing its CAD solutions as well as its new business portal, Medicexchange.com.
Medicexchange.com will provide medical imaging professionals with a unique global online community focused on delivering a multi-vendor sales channel for diagnostic, treatment and surgery planning solutions in a low-cost, on-demand and digitally-downloadable format. Combined with a variety of relevant clinical content, Medicexchange.com gives these professionals access to information and products that they would traditionally have difficulty accessing. The initial focus of Medicexchange.com, which is scheduled to be launched in July 2006, will be cardiac, thoracic, orthopedic, women’s and abdominal imaging.
“We are pleased to be working with William Blair & Co,” commented Tim Paterson-Brown, CEO of Medicsight. “The firm’s expertise and experience in the healthcare IT sector will be an important asset as we bring our LungCAD and ColonCAD solutions to market in the United States and abroad and enhance our product offerings. They will also be valuable advisors as we launch and build our new business portal, Medicexchange.com. We are confident they will make a positive contribution in improving shareholder value and liquidity as we emerge from a research and development stage to the commercialization of our products.”
About William Blair & Company
William Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, we have been committed to helping clients achieve their financial objectives. As an independent, employee-owned firm, our philosophy is to serve our clients’ interests first and foremost. We place a high value on the enduring nature of our client relationships, the quality of our products and services, and the continuity and integrity of our people. William Blair & Company has offices in Chicago, Hartford, London, San Francisco, Tokyo, Vaduz, and Zurich. For more information, please visit http://www.williamblair.com/ .
About Medicsight
Medicsight, Inc. is a leading developer of computer-aided detection (CAD) technologies and software, and operator of Medicexchange.com, an online multi-vendor sales channel for diagnostic, treatment and surgery planning solutions. Medicsight’s technology, which is developed by its subsidiary, Medicsight PLC, is tested using one of the world’s largest databases of verified CT scan data. Medicsight’s software solutions help clinicians identify, measure, and analyze suspicious pathology, such as colorectal polyps and lung lesions. The company’s CAD products include ColonCAD API, the first CAD technology available for CT colonography, and LungCAD API. Both products allow for a concurrent read that lets clinicians review the original image simultaneously with the Medicsight CAD findings, which results in improved workflow and productivity. Medicsight’s newest subsidiary, Medicexchange.com, is an online multi-vendor sales channel for diagnostic, treatment and surgery planning solutions for cardiac, thoracic, orthopedic, women’s and abdominal imaging. Medicexchange.com provides these solutions in a low-cost, on-demand and digitally-downloadable format for medical imaging professionals, providing access to information and products that they would traditionally have difficulty accessing. Headquartered in London, Medicsight employs more than 60 people and also has offices in the United States, Japan, and China. Product and company information can be found on http://www.medicsight.com. Stock symbol: MGT
All forward-looking statements are made pursuant to the ‘safe harbor’ provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.
Company contacts: For more information: Medicsight Investors David Mason, Stephanie Carrington, 646-536-7017 CEO, Medicsight USA Nick Laudico, 646-536-7030 615-665-9007
Medicsight, Inc.
CONTACT: David Mason of Medicsight, CEO, Medicsight USA, +1-615-665-9007,Investors - Stephanie Carrington, +1-646-536-7017, or Nick Laudico,+1-646-536-7030
